Please enable JS

ARTICLES & TESTIMONIALS

FILTER BY TYPE

Most Recent

Categories

ARCHIVES

Fail First/ Step Therapy Advocacy Update

Sep 26// Advocates in the news

We want to share a quick update and applaud one of our 50-State Network advocates Danielle Yevsa who spoke up about Fail First/ Step Therapy practices in the New York Daily News.

READ MORE

Salem resident testifies on biosimilar substitution bill

Feb 09// Advocates in the news

Salem resident Joni Johnston testified to the Missouri General Assembly’s House Emerging Issues Committee Jan. 20.

READ MORE

Arthritis: A Disease for All Generations

Jul 24// Advocates in the news

When Lauren Marchi entered college as a freshman at American University in Washington, DC, she was a classically trained pianist and ballerina. She had aspirations of pursuing degrees in piano performance and marketing while dancing on the side, but early in her senior year she was forced to question her well-laid plans.

READ MORE

MedPage Today – Providers, Patients Demand Transparency for Biosimilar Use

Jul 16// Advocates in the news

Katherine “Kat” Macfarlane, JD, who has rheumatoid arthritis and inflammatory eye disease, spoke at a briefing held at the House of Representatives on Monday about regulation of biosimilars.

READ MORE

The Salt Lake Tribune – Panel advances bill to keep doctors in the loop as biologic medicine frontier advances

Jul 10// Advocates in the news

The U.S. Food and Drug Administration is months away from approving the first biosimilar drugs, but a bill advanced by a legislative committee Monday would help Utah prepare for that day.

READ MORE

Delaware Online – State should pass ‘biosimilar’ bill for patient safety

Jul 10// Advocates in the news

For patients who are uninsured or underinsured, new treatments on the cutting edge of medicine called biosimilars have the potential to expand access and save lives.

READ MORE

Daily Record – Letter: Bill could bring relief to more patients

Jul 10// Advocates in the news

On June 8, the state Senate debated House No. 2477/Senate No. 1705, which provides a pathway in New Jersey for access to lower-cost mimic therapies of expensive biologic drugs.

READ MORE

DENVER BUSINESS JOURNAL – Cheaper generic biotech drugs loom as ‘biosimilars’ law advances in Colorado Legislature

Jul 10// Advocates in the news

The U.S. Food & Drug Administration approved the first generic version of a biotech drug for domestic sale Friday, hours after Colorado state legislators wrestled with how to let pharmacists handle cheaper biotech drug knockoffs.

READ MORE

Kat MacFarlane interview with Talk 107.3 Baton Rouge

May 05// Advocates in the news

Louisiana advocate Kat MacFarlane speak about the importance of physician/patient relationships, the promise of biosimilars when made available transparently, and why she is testifying about biosimilar substitution in the legislature.

READ MORE